首页> 外文期刊>Radiation oncology >Radiation-induced second malignancies after involved-node radiotherapy with deep-inspiration breath-hold technique for early stage Hodgkin Lymphoma: a dosimetric study
【24h】

Radiation-induced second malignancies after involved-node radiotherapy with deep-inspiration breath-hold technique for early stage Hodgkin Lymphoma: a dosimetric study

机译:早期霍奇金淋巴瘤受累结点放疗后采用深吸气屏气技术进行放疗引起的第二恶性肿瘤:剂量学研究

获取原文
           

摘要

Background To estimate the risk of radiation induced second cancers after radiotherapy using deep-inspiration breath-hold (DI) technique with three-dimensional conformal (3DCRT) and volumetric arc therapy (VMAT) for patients with Hodgkin’s lymphoma (HL). Methods Early-stage HL with mediastinal and supraclavicular involvement was studied using an Alderson phantom. A whole body CT was performed and all tissues were delineated. The clinical target volumes and planning target volumes (PTV) were determined according to the German Hodgkin study group guidelines. Free-breathing (FB) technique and DI technique were simulated by different safety margins for the PTV definition. In both cases, 30?Gy in 15 fractions was prescribed. Second cancer risk was estimated for various tissues with a second cancer model including fractionation. Results When compared with FB-3DCRT, estimated relative life time attributable risk (LAR) of cancer induction after DI-3DCRT was 0.86, 0.76, 0.94 and 0.92 for breast, lung, esophagus and stomach, respectively. With DI-VMAT, the corresponding values were 2.05, 1.29, 1.01, 0.93, respectively. For breast cancer, the LAR observed with DI-VMAT was not substantially distinguishable from the LAR computed for mantle RT with an administered dose of 40?Gy. Conclusions This study suggests that DI may reduce the LAR of secondary cancers of all OARs and may be a valuable technique when using 3DCRT. Conversely, VMAT may increase substantially the LAR and should be cautiously implemented in clinical practice.
机译:背景技术为了评估霍奇金淋巴瘤(HL)患者采用深呼吸屏气(DI)技术与三维共形(3DCRT)和容积弧线治疗(VMAT)进行放疗后发生放射诱发的第二种癌症的风险。方法使用Alderson体模研究早期纵隔和锁骨上牵涉的HL。进行了全身CT,并描绘了所有组织。根据德国霍奇金研究小组指南确定临床目标量和计划目标量(PTV)。针对PTV定义,通过不同的安全裕度模拟了自由呼吸(FB)技术和DI技术。在这两种情况下,均规定要在15馏分中加入30?Gy。使用包括分馏在内的第二种癌症模型估计了各种组织的第二种癌症风险。结果与FB-3DCRT相比,DI-3DCRT的乳腺癌,肺癌,食道和胃癌的相对终生归因风险(LAR)分别为0.86、0.76、0.94和0.92。使用DI-VMAT,相应的值分别为2.05、1.29、1.01、0.93。对于乳腺癌,DI-VMAT观察到的LAR与40?Gy剂量的套膜RT计算得出的LAR基本没有区别。结论这项研究表明DI可以降低所有OAR继发性癌症的LAR,并且在使用3DCRT时可能是一种有价值的技术。相反,VMAT可能会显着增加LAR,应在临床实践中谨慎实施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号